Agilect

Efficacia della Rasagilina in aggiunta alla Levo-Dopa nei pazienti con malattia di Parkinson e fluttuazioni motorie

La Rasagilina ( Agilect ) è un nuovo farmaco per la malattia di Parkinson. Il farmaco presenta attività inibitoria selettiva MAO-B, monoammino-ossidasi B. Lo studio LARGO ( Lasting effect in Adjunct therapy with Rasagiline Given Once daily, study ) ha valutato la sicurezza e l’efficacia del... (Articolo Completo)

Rasagiline as an adjunct to Levodopa in patients with Parkinson's disease and motor fluctuations

Management of patients with complications of Parkinson's disease remains a challenge for both the clinician and the patient. These complications may be a result of the natural course of the disease itself, or can be related to the treatments. Most patients receiving chronic Levodopa therapy ma... (Articolo Completo)